Goldman Sachs’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25.3M Buy
2,541,861
+682,227
+37% +$6.1M ﹤0.01% 2206
2025
Q4
$15.7M Sell
1,859,634
-9,237
-0.5% -$65.9K ﹤0.01% 2609
2025
Q3
$9.76M Sell
1,868,871
-66,296
-3% -$253K ﹤0.01% 2992
2025
Q2
$6.7M Sell
1,935,167
-142,828
-7% -$425K ﹤0.01% 3143
2025
Q1
$5.44M Sell
2,077,995
-627,974
-23% -$2.46M ﹤0.01% 3268
2024
Q4
$11.1M Buy
2,705,969
+730,504
+37% +$3.98M ﹤0.01% 2693
2024
Q3
$14M Buy
1,975,465
+490,947
+33% +$3.67M ﹤0.01% 2384
2024
Q2
$9.68M Sell
1,484,518
-278,630
-16% -$1.9M ﹤0.01% 2538
2024
Q1
$14.6M Buy
1,763,148
+779,761
+79% +$7.61M ﹤0.01% 2116
2023
Q4
$10.8M Buy
983,387
+91,782
+10% +$774K ﹤0.01% 2453
2023
Q3
$7.5M Sell
891,605
-397,846
-31% -$4.28M ﹤0.01% 2638
2023
Q2
$16.2M Sell
1,289,451
-109,648
-8% -$1.36M ﹤0.01% 2028
2023
Q1
$23M Buy
1,399,099
+125,684
+10% +$2.25M 0.01% 1693
2022
Q4
$19M Sell
1,273,415
-152,888
-11% -$2.93M 0.01% 2016
2022
Q3
$31.9M Buy
1,426,303
+466,520
+49% +$10.2M 0.01% 1459
2022
Q2
$16.1M Buy
959,783
+659,012
+219% +$14.1M ﹤0.01% 2080
2022
Q1
$9M Sell
300,771
-142,230
-32% -$3.45M ﹤0.01% 2798
2021
Q4
$13.6M Buy
443,001
+283,420
+178% +$8.96M ﹤0.01% 2484
2021
Q3
$5.03M Sell
159,581
-37,157
-19% -$1.25M ﹤0.01% 3360
2021
Q2
$7.2M Sell
196,738
-769,462
-80% -$25.4M ﹤0.01% 3014
2021
Q1
$33.4M Buy
966,200
+276,986
+40% +$12M 0.01% 1485
2020
Q4
$28.6M Buy
689,214
+582,855
+548% +$26.3M 0.01% 1560
2020
Q3
$4.53M Buy
+106,359
New +$4.06M ﹤0.01% 2983

Other funds holding RLAY